4,813 Shares of HCA Healthcare, Inc. $HCA Bought by Ulrich Consultants & Investment Group LLC

Ulrich Consultants & Investment Group LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 4,813 shares of the company’s stock, valued at approximately $2,054,000. HCA Healthcare comprises approximately 2.1% of Ulrich Consultants & Investment Group LLC’s portfolio, making the stock its 5th largest position.

A number of other institutional investors have also made changes to their positions in the business. BlackRock Inc. acquired a new stake in HCA Healthcare in the 2nd quarter valued at approximately $5,069,974,000. Wellington Management Group LLP raised its stake in shares of HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after purchasing an additional 799,761 shares in the last quarter. Darsana Capital Partners LP boosted its position in shares of HCA Healthcare by 46.7% during the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Legal & General Group Plc acquired a new stake in HCA Healthcare in the 2nd quarter valued at $410,992,000. Finally, Jupiter Topco LLC bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $371,138,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA opened at $460.42 on Wednesday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company has a 50 day simple moving average of $423.07 and a two-hundred day simple moving average of $419.09. The company has a market capitalization of $99.68 billion, a PE ratio of 15.44, a P/E/G ratio of 1.55 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.84 earnings per share. Research analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were issued a $0.78 dividend. The ex-dividend date was Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 10.45%.

Wall Street Analyst Weigh In

A number of analysts recently commented on HCA shares. Leerink Partners reiterated an “outperform” rating and issued a $492.00 price objective on shares of HCA Healthcare in a research report on Friday, September 18th. Wells Fargo & Company increased their price target on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 7th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Finally, Oppenheimer reduced their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $467.61.

HCA Healthcare Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.